Summary
An increase in circulating eosinophils was observed in patients with AIDS or ARC who were substituted for a period of 14 days with exogenous recombinant IL-2 in the context of a Phase I/II study. IL-2 exerts a broad range of biological properties and enhances the production of a variety of other cytokines, i.e., factors for haemopoietic cell growth and differentiation. After having excluded a direct effect of r IL-2 on haemopoietic precursor cells in semi-solid agar cultures, we developped a liquid culture system and studied the effect of patients' sera collected at different time intervals before, during and after r IL-2 substitution on cell differentiation of normal human bone-marrow cells in vitro. Patients' eosinophilia was preceded by a detectable activity in the sera which induced light-density, nonadherent bone-marrow cells to differentiate into the eosinophil lineage and was assessed by the presence of eosinophil primary granules or Luxol-fast blue positive granules. Thus, these in vitro data suggest the presence of circulating mediator(s) enhancing eosinophil production and differentiation in response to in vivo substitution of r IL-2.
This is a preview of subscription content, log in via an institution to check access.
References
Allen JR, Curran JW (1985) Epidemiology of the acquired immunodeficiency syndrome. In: Advances in Host Defense Mechanisms, Vo. 5, Gallin JI, Fauci AS (eds.) Raven Press, New York, 1
Bartelmez SH, Dodge WH, Mahmoud AAF, Bass DA (1980) Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen-cell-derived eosinophil growth-stimulating factor. Blood 56: 706
Ciobanu N, Welte, K, Kruger G, Venuta S, Gold J, Feldman SP, Wang CY, Koziner B, Moore MAS, Safai B, Mertelsmann R (1983) Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2. J Clin Immunol 3: 332
Czarnetzki BM, Pawelzik B (1983) The effect of eosinophil chemotactic factors on in vitro eosinopoiesis in the guinea pig. Blut 47: 287
De Stefano E, Friedman RM, Friedman-Kien AE, Goedert JJ, Henricksen D, Preble OT, Sonnabend JA, Vilcek J (1982) Acidlabile human leucocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis 146: 451
Donohue JA, Rosenstein M, Chang AE, Lotze MT, Robb RJ, Rosenberg SA (1984) The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. J Immunol 132: 2123
Ernst M, Kern P, Flad HD, Ulmer AJ (1985) Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with AIDS and ARC on phenotypes and functions of peripheral blood mononuclear cells (PBMC). J Clin Immunol 6
Goldberg J, McGuire LA, Williams WJ (1981) Myeloid Differentiation of human blood mononuclear cells in liquid culture. Blood 57: 497
Johnson GR, Metcalf D (1980) Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining. Exp Hematol 8: 549
Kern P, Toy J, Dietrich M (1985) Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS. Blut 50: 1
Lifson JD, Benike CJ, Mark DF, Koths K, Engleman EG (1984) In vitro effects of purified recombinant interleukin-2 on immune functions in patients with acquired immunodeficiency syndrome. In: Acquired Immune Deficiency Syndrome. Gottlieb MS, Groopman JE (eds.) Alan R. Liss, Inc., New York, 223
Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41: 4420
Lotze MT (1984) Clinical effects of IL-2. Presentation at IVth International Lymphokine Workshop, October 17–21, 1984, Schloß Elmau, Klais/Obb., West Germany
Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA (1985) In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the jurkat cell line-derivet interleukin 2. J Immunol 134: 157
Mazumder A, Rosenberg SA (1984) Successful immunotherapy of NK-resistant established pulmonary melanoma metastases by the intravenous transfer of syngeneic lymphocytes activated in vitro by interleukin-2. J Exp Med 159: 495
Mertelsmann R, Welte K (1984) Human interleukin-2. Clin Immunol All 4: 393
Mertelsmann, R. Personal Communication.
Moore RN, Larsen HS, Horohov DW, Rouse BT (1984) Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science 22: 178
Platzer E, Rubin BY, Lu L, Welte K, Broxmeyer HE, Moore MAS (1985) OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells. J Immunol 134: 265
Ruscetti FW, Gallo RT (1981) Human T-lymphocyte growth factor: Regulation of growth and function of T lymphocytes. Blood 57: 379
Sanderson CJ, Warren DJ, Strath M (1985) Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med 162: 60
Volberding PA, Wofsy CB, Abrams DI (1985) Interferon and interleukin-2 therapy of Kaposi's sarcoma. In: AIDS-associated Syndromes, Advances in Experimental Medicine and Biology. Gupta S (ed.). Vol. 187: 151
Vadas MA, Clark-Lewis I (1985) Regulation of human granulocyte function by products derived from murine tumors. Exp Hematol 13: 151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kern, P., Dietrich, M. Eosinophil differentiating activity in sera of patients with AIDS under recombinant IL-2 substitution. Blut 52, 249–254 (1986). https://doi.org/10.1007/BF00321085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00321085